MedTrace Logo

Clinical Evaluation of Day and Night Skin Care Creams Supplemented With MediCell Technology (MCT)'s Composition of Defensins and Supportive Molecules

NCT02765763 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 45

Last updated 2018-01-11

No results posted yet for this study

Summary

This is a placebo-controlled blinded clinical evaluation of day and night skin care creams supplemented by Medicell Technology's composition of defensins and supportive molecules determine the skin hydration and anti-aging properties of the topical test articles after repeated application to the skin of human subjects.

Conditions

  • Skin Aging
  • Photoaging of Skin

Interventions

DRUG

2-Minute Reveal Masque

DRUG

24/7 Barrier Repair Cream

DRUG

8-in-1 BioSerum

DRUG

Null Formula 2-Minute Reveal Masque

DRUG

Null Formula 24/7 Barrier Repair Cream

DRUG

Null Formula 8-in-1 BioSerum

Sponsors & Collaborators

  • Advanced Dermatology

    lead OTHER

Principal Investigators

  • Amy F Taub, MD · Advanced Dermatology. LLC

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
40 Years
Max Age
75 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-05-31
Primary Completion
2017-06-30
Completion
2017-06-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02765763 on ClinicalTrials.gov